Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | ABCLAbCellera Biologics Inc.FY2025 · Dec |
|---|---|
| Revenue | $75.13M |
| Revenue, yoy | +160.6% |
| Net income | $146.41M |
| Net income, yoy | +10.1% |
| Net margin | -194.9% |
| Free cash flow | $174.07M |
| FCF margin | -231.7% |
| EPS, diluted | $0.49 |
Add another company.